John Hendrick

Mr. Hendrick has over three decades of executive experience, building both early stage medical device companies as well as large divisions in Medical device Corporations. Currently, Mr. Hendrick is president and CEO of Mynosys Cellular Devices an ophthalmic company. Previously he was CEO of NeoVista Inc. a company in the field of Age Related Macular Degeneration. Prior to his accepting the role of CEO with Neovista, he created the Medical Division of Sanmina-Sci. Mr. Hendrick has been through a successful IPO of VidaMed which led eventually to the acquisition of the Company by Medtronic Inc. Prior to VidaMed, Mr. Hendrick held executive positions in Allergan Medical Optics, Baxter and American Hospital Supply along with several board positions.